Your browser doesn't support javascript.
loading
NF-κß signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities.
Killeen, Matthew J; Linder, Mark; Pontoniere, Paolo; Crea, Roberto.
Afiliação
  • Killeen MJ; CreAgri Inc., Hayward, CA, USA. Electronic address: matthew.killeen@gmail.com.
  • Linder M; CreAgri Inc., Hayward, CA, USA.
  • Pontoniere P; CreAgri Inc., Hayward, CA, USA.
  • Crea R; CreAgri Inc., Hayward, CA, USA.
Drug Discov Today ; 19(4): 373-8, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24246683
ABSTRACT
Chronic inflammation has a key role in the pathogenesis of multiple diseases that represent major public health and financial concerns, including heart failure (HF), Alzheimer's disease (AD) and arthritis. Nuclear factor kappa ß (NF-κß) is a central component of inflammation; owing to its upstream signaling position, it is considered an attractive target for new anti-inflammatory therapeutics. Hydroxytyrosol is an orally bioavailable polyphenol, obtained from olives, which inhibits NF-κß activity and has elicited promising efficacy signals in several inflammatory diseases. Here, we further examine the role of NF-κß in inflammation, provide an introduction to natural products and their anti-inflammatory effects and explore the potential of hydroxytyrosol as a new approach to combating the burden of chronic inflammatory diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Álcool Feniletílico / NF-kappa B / Anti-Inflamatórios Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Álcool Feniletílico / NF-kappa B / Anti-Inflamatórios Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article